- Home
- NOTV vs MDCX Comparison
NOTV vs MDCX Comparison
Compare NOTV & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- MDCX
- Stock Information
- Founded
- NOTV 1974
- MDCX 2008
- Country
- NOTV United States
- MDCX United States
- Employees
- NOTV N/A
- MDCX N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- NOTV Health Care
- MDCX
- Exchange
- NOTV Nasdaq
- MDCX Nasdaq
- Market Cap
- NOTV 46.7M
- MDCX 50.8M
- IPO Year
- NOTV 1997
- MDCX N/A
- Fundamental
- Price
- NOTV $1.43
- MDCX $2.29
- Analyst Decision
- NOTV Strong Buy
- MDCX Strong Buy
- Analyst Count
- NOTV 1
- MDCX 2
- Target Price
- NOTV $5.00
- MDCX $23.50
- AVG Volume (30 Days)
- NOTV 342.4K
- MDCX 402.4K
- Earning Date
- NOTV 12-02-2025
- MDCX 11-22-2025
- Dividend Yield
- NOTV N/A
- MDCX N/A
- EPS Growth
- NOTV N/A
- MDCX N/A
- EPS
- NOTV N/A
- MDCX N/A
- Revenue
- NOTV $505,299,000.00
- MDCX N/A
- Revenue This Year
- NOTV $5.64
- MDCX N/A
- Revenue Next Year
- NOTV $5.16
- MDCX N/A
- P/E Ratio
- NOTV N/A
- MDCX N/A
- Revenue Growth
- NOTV 0.85
- MDCX N/A
- 52 Week Low
- NOTV $1.15
- MDCX $1.79
- 52 Week High
- NOTV $6.48
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- NOTV 44.87
- MDCX 47.86
- Support Level
- NOTV $1.25
- MDCX $2.33
- Resistance Level
- NOTV $1.55
- MDCX $2.70
- Average True Range (ATR)
- NOTV 0.12
- MDCX 0.20
- MACD
- NOTV 0.01
- MDCX -0.02
- Stochastic Oscillator
- NOTV 43.24
- MDCX 32.67
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.